Dr David M Barrs, MD | |
5779 E Mayo Blvd, Phoenix, AZ 85054 | |
(480) 301-8000 | |
Not Available |
Full Name | Dr David M Barrs |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Location | 5779 E Mayo Blvd, Phoenix, Arizona |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1346224979 | NPI | - | NPPES |
756778 | Medicaid | AZ | |
86080015085259A861 | Other | AZ | TRIWEST |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | 17975 (Arizona) | Primary |
Entity Name | District Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1336472448 PECOS PAC ID: 7315086691 Enrollment ID: O20091125000583 |
News Archive
A simple non-surgical gum disease treatment markedly reduces the thickness of the wall of the arteries, a risk factor for heart disease, according to a first of its kind study among Aboriginal Australians.
The second-generation proteasome inhibitor carfilzomib is showing noteworthy response rates and low levels of adverse side effects among multiple myeloma patients in a phase II clinical trial, researchers reported today at the 51st Annual Meeting of the American Society of Hematology.
Getting to the bottom of Alzheimer's disease has been a rapidly evolving pursuit with many twists, turns and controversies. In the latest crook in the research road, scientists have found a new insight into the interaction between proteins associated with the disease. The report, which appears in the journal ACS Chemical Neuroscience, could have important implications for developing novel treatments.
Nearly ten percent of all cases of depression are so severe that the patients do not respond to any established treatment method. Targeted stimulation of areas in the brain using a type of "brain pacemaker" has recently raised hopes: According to initial studies, half of patients with the most severe depression treated in this manner see a significant improvement in mood.
When the most common adult leukemia in the United States was last reviewed by the New England Journal of Medicine (NEJM) in 1995, it was seen through the eyes of theories that dated back to the 1960s.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr David M Barrs, MD 5779 E Mayo Blvd, Phoenix, AZ 85054 Ph: (480) 301-8000 | Dr David M Barrs, MD 5779 E Mayo Blvd, Phoenix, AZ 85054 Ph: (480) 301-8000 |
News Archive
A simple non-surgical gum disease treatment markedly reduces the thickness of the wall of the arteries, a risk factor for heart disease, according to a first of its kind study among Aboriginal Australians.
The second-generation proteasome inhibitor carfilzomib is showing noteworthy response rates and low levels of adverse side effects among multiple myeloma patients in a phase II clinical trial, researchers reported today at the 51st Annual Meeting of the American Society of Hematology.
Getting to the bottom of Alzheimer's disease has been a rapidly evolving pursuit with many twists, turns and controversies. In the latest crook in the research road, scientists have found a new insight into the interaction between proteins associated with the disease. The report, which appears in the journal ACS Chemical Neuroscience, could have important implications for developing novel treatments.
Nearly ten percent of all cases of depression are so severe that the patients do not respond to any established treatment method. Targeted stimulation of areas in the brain using a type of "brain pacemaker" has recently raised hopes: According to initial studies, half of patients with the most severe depression treated in this manner see a significant improvement in mood.
When the most common adult leukemia in the United States was last reviewed by the New England Journal of Medicine (NEJM) in 1995, it was seen through the eyes of theories that dated back to the 1960s.
› Verified 6 days ago
Dr. Shawn Michael Stevens, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2910 N 3rd Ave # 330, Phoenix, AZ 85013 Phone: 602-406-8811 Fax: 602-406-8810 | |
Charles R Orozco, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4250 E Camelback, Suite K-250, Phoenix, AZ 85018 Phone: 602-253-9026 Fax: 602-252-6391 | |
John David Macias, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1515 N 9th St, Suite B, Phoenix, AZ 85006 Phone: 602-257-4228 Fax: 602-252-6416 | |
Dr. Michael L Hinni, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5779 E Mayo Blvd, Phoenix, AZ 85054 Phone: 480-301-8000 | |
Randy Oppenheimer, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 2601 E Roosevelt St, Department Of Surgery, Phoenix, AZ 85008 Phone: 602-344-5608 Fax: 602-344-1299 | |
Austin N Dehart, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 1920 E Cambridge Ave Ste 201, Phoenix, AZ 85006 Phone: 602-933-3277 Fax: 602-933-4326 | |
Griffin Santarelli, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2910 N 3rd Ave # 330, Phoenix, AZ 85013 Phone: 602-406-8811 Fax: 602-406-8810 |